BACKGROUND: Evidence-based treatment protocols including therapeutic hypothermia have increased hospital survival to over 50% in unconscious out-of-hospital cardiac arrest survivors. In this study we estimated the incidence of cognitive dysfunctions in a group of cardiac arrest survivors with a high functional outcome treated with therapeutic hypothermia. Secondarily, we assessed the cardiac arrest group's level of cognitive performance in each tested cognitive domain and investigated the relationship between cognitive function and age, time since cardiac arrest and health-related quality of life (HRQOL). METHODS: We included 26 patients 13-28 months after a cardiac arrest. All patients were scored using the Cerebral Performance Category scale (CPC) and Mini-Mental State Examination (MMSE). Twenty-five of the patients were tested for cognitive function using the Cambridge Neuropsychological Test Automated Battery (CANTAB). These patients were tested using four cognitive tests: Motor Screening Test, Delayed Matching to Sample, Stockings of Cambridge and Paired Associate Learning from CANTAB. All patients filled in the Short Form-36 for the assessment of HRQOL. RESULTS: Thirteen of 25 (52%) patients were classified as having a cognitive dysfunction. Compared with the reference population, there was no difference in the performance in motor function and delayed memory but there were significant differences in executive function and episodic memory. We found no associations between cognitive function and age, time since cardiac arrest or HRQOL. CONCLUSION: Half of the patients had a cognitive dysfunction with reduced performance on executive function and episodic memory, indicating frontal and temporal lobe affection, respectively. Reduced performance did not affect HRQOL.
BACKGROUND: Evidence-based treatment protocols including therapeutic hypothermia have increased hospital survival to over 50% in unconscious out-of-hospital cardiac arrest survivors. In this study we estimated the incidence of cognitive dysfunctions in a group of cardiac arrest survivors with a high functional outcome treated with therapeutic hypothermia. Secondarily, we assessed the cardiac arrest group's level of cognitive performance in each tested cognitive domain and investigated the relationship between cognitive function and age, time since cardiac arrest and health-related quality of life (HRQOL). METHODS: We included 26 patients 13-28 months after a cardiac arrest. All patients were scored using the Cerebral Performance Category scale (CPC) and Mini-Mental State Examination (MMSE). Twenty-five of the patients were tested for cognitive function using the Cambridge Neuropsychological Test Automated Battery (CANTAB). These patients were tested using four cognitive tests: Motor Screening Test, Delayed Matching to Sample, Stockings of Cambridge and Paired Associate Learning from CANTAB. All patients filled in the Short Form-36 for the assessment of HRQOL. RESULTS: Thirteen of 25 (52%) patients were classified as having a cognitive dysfunction. Compared with the reference population, there was no difference in the performance in motor function and delayed memory but there were significant differences in executive function and episodic memory. We found no associations between cognitive function and age, time since cardiac arrest or HRQOL. CONCLUSION: Half of the patients had a cognitive dysfunction with reduced performance on executive function and episodic memory, indicating frontal and temporal lobe affection, respectively. Reduced performance did not affect HRQOL.
Authors: Joel Kohler; Friedrich Borchers; Matthias Endres; Björn Weiss; Claudia Spies; Julius Valentin Emmrich Journal: Dtsch Arztebl Int Date: 2019-09-20 Impact factor: 5.594
Authors: Alessandro Putzu; Silvia Valtorta; Giuseppe Di Grigoli; Matthias Haenggi; Sara Belloli; Antonio Malgaroli; Marco Gemma; Giovanni Landoni; Luigi Beretta; Rosa Maria Moresco Journal: Neurocrit Care Date: 2018-06 Impact factor: 3.210
Authors: Jennifer E Fugate; Samuel A Moore; David S Knopman; Daniel O Claassen; Eelco F M Wijdicks; Roger D White; Alejandro A Rabinstein Journal: Neurology Date: 2013-05-17 Impact factor: 9.910
Authors: Stephen Iannacone; Marion Leary; Emily C Esposito; Kosha Ruparel; Adam Savitt; Allison Mott; Jan A Richard; Ruben C Gur; Benjamin S Abella Journal: Ther Hypothermia Temp Manag Date: 2014-07-10 Impact factor: 1.286
Authors: Jake T Neumann; Charles H Cohan; Kunjan R Dave; Clinton B Wright; Miguel A Perez-Pinzon Journal: Curr Drug Targets Date: 2013-01-01 Impact factor: 3.465
Authors: Beth S Slomine; Faye S Silverstein; James R Christensen; Kent Page; Richard Holubkov; J Michael Dean; Frank W Moler Journal: JAMA Neurol Date: 2018-12-01 Impact factor: 18.302